Cholescintigraphic measurement of liver function: How is it different from other methods?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 10, 2006, Pages 1103-1106

  Krishnamurthy, Gerbail T ^a   Krishnamurthy, Shakuntala ^a  

^a Tuality Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOFENIN TC 99M; MEBROFENIN TC 99M;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CELL DEATH; EDITORIAL; ENZYME BLOOD LEVEL; GALLBLADDER SCINTISCANNING; GENE EXPRESSION REGULATION; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER METABOLISM; NONHUMAN;

ANIMALS; FATTY LIVER; IMINO ACIDS; LIVER; MODELS, BIOLOGICAL; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS;

EID: 33749236641     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0182-7     Document Type: Editorial

References (14)

1. Boyer JL. Nuclear receptor ligands: rational and effective therapy for cholestatic liver disease. Gastroenterology 2005;129:735-740
2. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006;43:S32-S44
3. Krishnamurthy GT, Krishnamurthy S. Nuclear hepatology: a textbook of hepatobiliary diseases. New York: Springer;2000
4. Klingensmith WC III, Whitney WP, Spitzer VM, Klintmalm GB, Koep LM, Kuni CC. Effect of complete biliary-tract obstruction on serial hepatobiliary imaging in an experimental model: concise communication. J Nucl Med 1981;22:866-868
5. Krishnamurthy GT, Krishnamurthy S. Pathophysiology of acute critical obstruction of the common bile duct: role of quantitative cholescintigraphy and ultrasound in early detection and patient management. Indian J Nucl Med 2003;18:66-72
6. Lieberman DA, Brown PH, Krishnamurthy GT. Improved scintigraphic assessment of severe cholestasis with the hepatic extraction fraction. Dig Dis Sci 1990;35:1385-1390
7. Vetelainen RL, Bennick RJ, deBruin K, vanVliet AK, vanGulic TM. Hepatobiliary function assessed by Tc-99m mebrofenin scintigraphy correlates with the severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging 2006; DOI 10.1007/s00259-006-0125-3
8. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-210
9. Lemasters JJ. Dying a thousand deaths: redundant pathway from different organelles to apoptosis and necrosis. Gastroenterology 2005;129:351-360
10. Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003;38:345-354
11. Hartman G, Cheung AK, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate the expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 2002;303:273-281
12. Joseph B, Bhargava KK, Tronco G, Kumaran V, Palestro CJ, Gupta S. Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation. J Nucl Med 2005;46:146-152
13. Malhi H, Bhargava KK, Afriyie MO, Volenberg I, Schilsky ML, Palestro CJ, et al. Technetium-99m mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease. J Nucl Med 2002;43:246-252
14. Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 2006;130:810-822